These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 8185681)
1. Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function. Barnette MS; Rush J; Marshall LA; Foley JJ; Schmidt DB; Sarau HM Biochem Pharmacol; 1994 Apr; 47(9):1661-7. PubMed ID: 8185681 [TBL] [Abstract][Full Text] [Related]
2. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900 [TBL] [Abstract][Full Text] [Related]
3. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation. Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982 [TBL] [Abstract][Full Text] [Related]
4. Regulation of CD11b/CD18 expression in human neutrophils by phospholipase A2. Jacobson PB; Schrier DJ J Immunol; 1993 Nov; 151(10):5639-52. PubMed ID: 8228253 [TBL] [Abstract][Full Text] [Related]
5. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Payá M; Terencio MC; Ferrándiz ML; Alcaraz MJ Br J Pharmacol; 1996 Apr; 117(8):1773-9. PubMed ID: 8732290 [TBL] [Abstract][Full Text] [Related]
6. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2. Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196 [TBL] [Abstract][Full Text] [Related]
7. Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. Shibata K; Yoshino H; Mizuno N; Shinohara H; Morita K; Kitayama S; Kurihara H; Dohi T Prostaglandins Other Lipid Mediat; 2000 Oct; 62(4):385-94. PubMed ID: 11060901 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of phospholipase A2 activities and some inflammatory responses by the marine product ircinin. Cholbi R; Ferrándiz ML; Terencio MC; De Rosa S; Alcaraz MJ; Payá M Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):677-83. PubMed ID: 8938669 [TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation. Bauldry SA; Wooten RE Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854 [TBL] [Abstract][Full Text] [Related]
11. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4. Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028 [TBL] [Abstract][Full Text] [Related]
12. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils. Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of some compounds on human neutrophil degranulation and leukotriene B4 and thromboxane B2 synthesis. Palmer RM; Salmon JA Biochem Pharmacol; 1985 May; 34(9):1485-90. PubMed ID: 2986647 [TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4. Reddy S; Bose R; Rao GH; Murthy M Am J Physiol; 1995 Jan; 268(1 Pt 1):C138-46. PubMed ID: 7840141 [TBL] [Abstract][Full Text] [Related]
15. Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluent. Daniels I; Lindsay MA; Keany CI; Burden RP; Fletcher J; Haynes AP Clin Diagn Lab Immunol; 1998 Sep; 5(5):683-9. PubMed ID: 9729536 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of human neutrophil function by tolfenamic acid involves inhibition of Ca2+ influx. Kankaanranta H; Wuorela H; Siltaloppi E; Vuorinen P; Vapaatalo H; Moilanen E Eur J Pharmacol; 1995 Sep; 291(1):17-25. PubMed ID: 8549643 [TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982. Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049 [TBL] [Abstract][Full Text] [Related]
18. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils. Rossi AG; McMillan RM; MacIntyre DE Agents Actions; 1988 Jul; 24(3-4):272-82. PubMed ID: 2845744 [TBL] [Abstract][Full Text] [Related]
19. Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial. Novel effects independent of inhibition of lipid mediator production. Glaser KB; Lock YW Biochem Pharmacol; 1995 Sep; 50(7):913-22. PubMed ID: 7575673 [TBL] [Abstract][Full Text] [Related]
20. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils. Koike H; Imanishi N; Natsume Y; Morooka S Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]